These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 27113954)
21. Glycopyrrolate for treatment of clozapine-induced sialorrhea in three adolescents. Robb AS; Lee RH; Cooper EB; Siedel JV; Nusrat N J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):99-107. PubMed ID: 18294092 [TBL] [Abstract][Full Text] [Related]
28. Sublingual atropine in the treatment of clozapine-induced sialorrhea. Matos Santana TE; Capurso NA; Ranganathan M; Yoon G Schizophr Res; 2017 Apr; 182():144-145. PubMed ID: 27816262 [No Abstract] [Full Text] [Related]
29. Sulpiride addition for the treatment of clozapine-induced hypersalivation: preliminary study. Kreinin A; Epshtein S; Sheinkman A; Tell E Isr J Psychiatry Relat Sci; 2005; 42(1):61-3. PubMed ID: 16134408 [TBL] [Abstract][Full Text] [Related]
30. The effect of sublingual atropine sulfate on clozapine-induced hypersalivation: a multicentre, randomised placebo-controlled trial. Mubaslat O; Lambert T Psychopharmacology (Berl); 2020 Oct; 237(10):2905-2915. PubMed ID: 32876732 [TBL] [Abstract][Full Text] [Related]
31. Potential use of ipatropium bromide for the treatment of clozapine-induced hypersalivation: a preliminary report. Calderon J; Rubin E; Sobota WL Int Clin Psychopharmacol; 2000 Jan; 15(1):49-52. PubMed ID: 10836287 [TBL] [Abstract][Full Text] [Related]
32. Biperiden for excessive sweating from clozapine. Richardson C; Kelly DL; Conley RR Am J Psychiatry; 2001 Aug; 158(8):1329-30. PubMed ID: 11481174 [No Abstract] [Full Text] [Related]
33. Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study. Liang CS; Ho PS; Shen LJ; Lee WK; Yang FW; Chiang KT Schizophr Res; 2010 Jun; 119(1-3):138-44. PubMed ID: 20299191 [TBL] [Abstract][Full Text] [Related]
34. Therapeutic options in the treatment of clozapine-induced sialorrhea. Rogers DP; Shramko JK Pharmacotherapy; 2000 Sep; 20(9):1092-5. PubMed ID: 10999502 [TBL] [Abstract][Full Text] [Related]
35. Effectiveness of the repeated administration of scopolamine ointment on clozapine-induced hypersalivation in patients with treatment-resistant schizophrenia: A preliminary study. Takeuchi I; Hanya M; Uno J; Fujita K; Kamei H Asia Pac Psychiatry; 2017 Dec; 9(4):. PubMed ID: 29193710 [TBL] [Abstract][Full Text] [Related]
36. Prevalence of clozapine-induced sialorrhea and its effect on quality of life. Sanagustin D; Martin-Subero M; Hogg B; Fortea L; Gardoki I; Guinart D; Roldán M; Angelats M; Cerro L; Navas D; Jiménez JD; Ortiz L; Ros R; Polo X; Ventura Y; Contreras J; Moreno-Alcázar A; Pérez-Sola V; Amann BL; Valiente-Gómez A Psychopharmacology (Berl); 2023 Jan; 240(1):203-211. PubMed ID: 36538098 [TBL] [Abstract][Full Text] [Related]
37. Moclobemide treatment of clozapine-induced hypersalivation: pilot open study. Kreinin A; Miodownik C; Libov I; Shestakova D; Lerner V Clin Neuropharmacol; 2009; 32(3):151-3. PubMed ID: 19483481 [TBL] [Abstract][Full Text] [Related]
38. Clozapine and sialorrhea: a new intervention for this bothersome and potentially dangerous side effect. Antonello C; Tessier P J Psychiatry Neurosci; 1999 May; 24(3):250. PubMed ID: 10354662 [No Abstract] [Full Text] [Related]
39. Salivary flow rate in patients with schizophrenia on clozapine. Praharaj SK; Jana AK; Goswami K; Das PR; Goyal N; Sinha VK Clin Neuropharmacol; 2010 Jul; 33(4):176-8. PubMed ID: 20661023 [TBL] [Abstract][Full Text] [Related]